Figure 5From: The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions The biochemical recurrence-free rate stratified by biologically effective dose (BED) using the definition of PSA ≥ 0.2 ng/mL BCR: biochemical recurrence. Back to article page